Ignite Creation Date:
2025-12-24 @ 12:02 PM
Ignite Modification Date:
2025-12-24 @ 12:02 PM
Study NCT ID:
NCT00457561
Status:
COMPLETED
Last Update Posted:
2007-04-06
First Post:
2007-04-05
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis
Sponsor:
Hamamatsu University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2007-04-05
First Submit QC Date:
None
Study First Post Date:
2007-04-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-04-05
Last Update Post Date:
2007-04-06
Last Update Post Date Type:
ESTIMATED